Jamal Mahajna

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

International journal of molecular sciences

Cancers

Nutrients

Molecules (Basel, Switzerland)

Migal Galilee Technology Center

Hebrew University of Jerusalem (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Migal Galilee Technology Center

Israel

Head of Department

Education History

Hebrew University of Jerusalem

Israel

PHD

Publications

Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya, Jamal Mahajna
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. Cancers 16 (13) (2024)
Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya, Jamal Mahajna
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. Cancers 16 (13) (2024)
Yifat Koren Carmi, Hazem Khamaisi, Rina Adawi, Eden Noyman, Jacob Gopas, Jamal Mahajna
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells. International journal of molecular sciences 24 (9) (2023)
Yifat Koren Carmi, Hazem Khamaisi, Rina Adawi, Eden Noyman, Jacob Gopas, Jamal Mahajna
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells. International journal of molecular sciences 24 (9) (2023)
Rosita Gabbianelli, Ehud Shahar, Gaia de Simone, Chiara Rucci, Laura Bordoni, Giulia Feliziani, Fanrui Zhao, Marta Ferrati, Filippo Maggi, Eleonora Spinozzi, Jamal Mahajna
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. Nutrients 15 (22) (2023)
Hazem Khamaisi, Hatem Mahmoud, Jamal Mahajna
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion. Molecules (Basel, Switzerland) 27 (3) (2022)
Ari Meerson, Soliman Khatib, Jamal Mahajna
Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics. International journal of molecular sciences 22 (23) (2021)
Izabela Koss-Mikołajczyk, Vanja Todorovic, Sladjana Sobajic, Jamal Mahajna, Marko Gerić, Josep Antonio Tur, Agnieszka Bartoszek
Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review. International journal of molecular sciences 22 (18) (2021)
Yifat Koren Carmi, Hatem Mahmoud, Hazem Khamaisi, Rina Adawi, Jacob Gopas, Jamal Mahajna
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion. International journal of molecular sciences 21 (18) (2020)

Jamal Mahajna.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jamal Mahajna